The ReInforcement of adherence via self-monitoring app orchestrating biosignals and medication of RivaroXaban in patients with atrial fibrillation and co-morbidities: a study protocol for a randomized controlled trial (RIVOX-AF)

BACKGROUND: Because of the short half-life of non-vitamin K antagonist oral anticoagulants (NOACs), consistent drug adherence is crucial to maintain the effect of anticoagulants for stroke prevention in atrial fibrillation (AF). Considering the low adherence to NOACs in practice, we developed a mobi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Minjae, Park, Jin Joo, Hur, Taeho, Hua, Cam-Hao, Shim, Chi Young, Yoo, Byung-Su, Cho, Hyun-Jai, Lee, Seonhwa, Kim, Hyue Mee, Kim, Ji-Hyun, Lee, Sungyoung, Choi, Dong-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263056/
https://www.ncbi.nlm.nih.gov/pubmed/37324622
http://dx.doi.org/10.3389/fcvm.2023.1130216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263056/
https://www.ncbi.nlm.nih.gov/pubmed/37324622
http://dx.doi.org/10.3389/fcvm.2023.1130216

Ejemplares similares